Epigenetics Market to 2025 - Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments & Consumables and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation and Others), Application (Oncology, Cardiovascular Diseases and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) and Geography
- THE3206897
- 160 Pages
- January 2019
- Diagnostic and Biotech
The epigenetics market is driven by the driving factor such as declining prices of sequencing, and is likely to drive the market in the coming years. The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market.The market is likely to restrain its growth due to the factors such as high cost of advanced technologies. Companies such as Illumina and PacBio offer instruments with high cost. For instance, Illumina MiSeq cost for US$ 128,000 and PacBio RS cost for US$ 695,000. Thus, the high cost of next generation sequencers is hindering the growth of the market for in the future. Whereas the use of the neuroepigenetics to diagnose the neurodevelopmental disorders is likely to contribute a potential market growth in the forecast period.
The epigenetics market as per the product the segment is segmented as reagents, kits, enzymes, instruments and consumables and bioinformatics tools. The market of kits has the highest market share in 2017, contributing a market share of 29.8% and is expected to retain its dominance during the forecast period from 2018 to 2025. The epigenetic kits allows researchers to perform experiments, researchers to analyze epigenetic modifications efficiently and reliably by using antibodies directed against epitope tags or RNA-binding proteins. Thus holding the major market share. Likewise the reagents contributed 26.2% of the market share in the year 2017 and is expected to be the fastest growing market in the coming near future.
The technology segment of the epigenetics market includes histone modification, DNA methylation and other technologies. The DNA methylation segment for the epigenetics market was valued at US$ 506.29 Mn in 2017 and is estimated to grow at a CAGR of 13.9% during the forecast period from 2017 to 2025, to reach US$ 1,361.67.0 Mn by 2025. The DNA methylation segments is likely to dominate the market in the coming future as it supports the development of therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects. Thus the DNA methylation segment is expected to hold major share and is also the fastest growing segment during the forecast period.
Some of the major primary and secondary sources included in the report epigenetics market are National Institute of Environmental Health Sciences (NIEHS), Epidemiology and Genomics Research Program (EGRP), Canadian Institutes of Health Research (CIHR), Synthetic Biology Leadership Council, Chinese Academy of Sciences, World Health Organization, European Union, Food and Drug Administration and more.
1. INTRODUCTION 22
1.1 SCOPE OF THE STUDY 22
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 22
2. GLOBAL EPIGENETICS MARKET - KEY TAKEAWAYS 24
3. GLOBAL EPIGENETICS MARKET - MARKET LANDSCAPE 27
3.1 OVERVIEW 27
3.2 MARKET SEGMENTATION 27
3.2.1 Global Epigenetics Market - By Product 28
3.2.2 Global Epigenetics Market - By Technology 28
3.2.3 Global Epigenetics Market - By Application 29
3.2.4 Global Epigenetics Market - By End User 29
3.2.5 Global Epigenetics Market - By Geography 29
4. GLOBAL EPIGENETICS MARKET - KEY MARKET DYNAMICS 30
4.1 KEY MARKET DRIVERS 30
4.1.1 Declining Prices of Sequencing 30
4.1.2 Increasing Prevalence of Cancer 30
4.1.3 Funds & Grants Provided By Government Bodies 30
4.2 KEY MARKET RESTRAINTS 31
4.2.1 High Cost of Advanced Technologies 31
4.2.2 Perception of the People For Genetic Alteration 31
4.3 KEY MARKET OPPORTUNITIES 32
4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine 32
4.3.2 Emerging Nations 32
4.4 KEY MARKET CHALLENGE 33
4.4.1 Lack of Skilled Professionals 33
4.5 FUTURE TRENDS 33
4.5.1 Promising Precise Treatments by Neurogenetics 33
4.6 IMPACT ANALYSIS 34
5. EPIGENETICS MARKET - GLOBAL ANALYSIS 35
5.1 GLOBAL EPIGENETICS MARKET REVENUE FORECASTS AND ANALYSIS 35
5.2 GLOBAL EPIGENETICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 36
5.3 MARKET POSITIONING 37
5.4 PERFORMANCE OF KEY PLAYERS 37
5.4.1 Thermo Fisher Scientific Inc. 37
5.4.2 Illumina, Inc. 37
5.5 EXPERT OPINIONS 38
6. GLOBAL EPIGENETICS MARKET ANALYSIS - BY PRODUCT 39
6.1 OVERVIEW 39
6.2 GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2017 & 2025 (%) 39
6.3 REAGENTS MARKET 40
6.3.1 Overview 40
6.3.2 Global Reagents Market Revenue and Forecasts to 2025 (US$ Mn) 40
6.4 KITS MARKET 41
6.4.1 Overview 41
6.4.2 Global Kits Market Revenue and Forecasts to 2025 (US$ Mn) 41
6.5 ENZYMES MARKET 42
6.5.1 Overview 42
6.5.2 Global Enzymes Market Revenue and Forecasts to 2025 (US$ Mn) 42
6.6 INSTRUMENTS AND CONSUMABLES MARKET 43
6.6.1 Overview 43
6.6.2 Global Instruments and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 44
6.7 BIOINFORMATICS TOOLS MARKET 45
6.7.1 Overview 45
6.7.2 Global Bioinformatics Tools Market Revenue and Forecasts to 2025 (US$ Mn) 45
7. GLOBAL EPIGENETICS MARKET ANALYSIS - BY TECHNOLOGY 46
7.1 OVERVIEW 46
7.2 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%) 46
7.3 HISTONE MODIFICATION MARKET 47
7.3.1 Overview 47
7.3.2 Global Histone Modification Market Revenue and Forecasts to 2025 (US$ Mn) 47
7.4 DNA METHYLATION MARKET 48
7.4.1 Overview 48
7.4.2 Global DNA Methylation Market Revenue and Forecasts to 2025 (US$ Mn) 48
7.5 OTHER TECHNOLOGIES MARKET 49
7.5.1 Overview 49
7.5.2 Global Other Technologies Market Revenue and Forecasts to 2025 (US$ Mn) 49
8. GLOBAL EPIGENETICS MARKET ANALYSIS - BY APPLICATION 50
8.1 OVERVIEW 50
8.2 GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2017 & 2025 (%) 50
8.3 METABOLIC DISEASES MARKET 51
8.3.1 Overview 51
8.3.2 Global Metabolic Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 51
8.4 ONCOLOGY MARKET 52
8.4.1 Overview 52
8.4.2 Global Oncology Market Revenue and Forecasts to 2025 (US$ Mn) 52
8.5 CARDIOVASCULAR DISEASES MARKET 53
8.5.1 Overview 53
8.5.2 Global Cardiovascular Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 54
8.6 OTHER APPLICATIONS MARKET 55
8.6.1 Overview 55
8.6.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 55
9. GLOBAL EPIGENETICS MARKET ANALYSIS - BY END USER 56
9.1 OVERVIEW 56
9.2 GLOBAL EPIGENETICS MARKET, BY END USER, 2017 & 2025 (%) 56
9.3 ACADEMIC & RESEARCH INSTITUTES MARKET 57
9.3.1 Overview 57
9.3.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 57
9.4 CONTRACT RESEARCH ORGANIZATIONS MARKET 58
9.4.1 Overview 58
9.4.2 Global Contract Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn) 58
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 59
9.5.1 Overview 59
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn) 59
10. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 60
10.1 OVERVIEW 60
10.2 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
10.3 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
10.4 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
10.5 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
10.6 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
10.7 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
10.8 US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
10.8.1 US Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 65
10.8.2 US Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 65
10.8.3 US Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 66
10.8.4 US Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
10.8.5 US Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 66
10.9 CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
10.9.1 Canada Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 68
10.9.2 Canada Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68
10.9.3 Canada Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 69
10.9.4 Canada Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 69
10.9.5 Canada Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 69
10.10 MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
10.10.1 Mexico Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 71
10.10.2 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
10.10.3 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 72
10.10.4 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 72
10.10.5 Mexico Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 72
11. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 73
11.1 OVERVIEW 73
11.2 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
11.3 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
11.4 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
11.5 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
11.6 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
11.7 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
11.8 UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
11.8.1 UK Epigenetics market Revenue and Forecasts to 2025 (US$ Mn) 78
11.8.2 UK Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 78
11.8.3 UK Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 79
11.8.4 UK Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
11.8.5 UK Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 79
11.9 GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
11.9.1 Germany Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 80
11.9.2 Germany Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 81
11.9.3 Germany Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 81
11.9.4 Germany Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81
11.9.5 Germany Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 82
11.10 FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
11.10.1 France Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 84
11.10.2 France Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 84
11.10.3 France Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 85
11.10.4 France Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 85
11.10.5 France Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 85
12. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 86
12.1 OVERVIEW 86
12.2 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
12.3 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
12.4 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
12.5 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
12.6 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
12.7 ASIA PACIFIC GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
12.8 CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
12.8.1 China Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 90
12.8.2 China Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
12.8.3 China Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 91
12.8.4 China Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91
12.8.5 China Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 91
12.9 JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
12.9.1 Japan Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 92
12.9.2 Japan Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
12.9.3 Japan Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 93
12.9.4 Japan Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
12.9.5 Japan Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94
12.10 INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95
12.10.1 India Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 96
12.10.2 India Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 96
12.10.3 India Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 97
12.10.4 India Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 97
12.10.5 India Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 97
13. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 98
13.1 OVERVIEW 98
13.2 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
13.3 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
13.4 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
13.5 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
13.6 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
13.7 MIDDLE EAST AND AFRICA AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
13.8 UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
13.8.1 UAE Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 103
13.8.2 UAE Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
13.8.3 UAE Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 104
13.8.4 UAE Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
13.8.5 UAE Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104
13.9 SAUDI ARABIA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
13.10 SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
13.10.1 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 106
13.10.2 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 106
13.10.3 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106
13.10.4 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 107
13.11 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107
13.12 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
13.12.1 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108
13.12.2 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 109
13.12.3 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 109
13.12.4 South Africa Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 109
14. SOUTH AND CENTRAL AMERICA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 110
14.1 OVERVIEW 110
14.2 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
14.3 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
14.4 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
14.5 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
14.6 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
14.7 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
14.8 BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
14.8.1 Brazil Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 114
14.8.2 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 115
14.8.3 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 115
14.8.4 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 115
14.8.5 Brazil Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 116
15. EPIGENETICS MARKET -INDUSTRY LANDSCAPE 117
15.1 OVERVIEW 117
15.2 GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
15.3 ORGANIC GROWTH STRATEGIES 118
15.3.1 Overview 118
15.3.2 Product Launches 118
15.3.3 Others 119
15.4 INORGANIC GROWTH STRATEGIES 119
15.4.1 Overview 119
15.4.2 Agreements 120
15.4.3 Acquisition 121
16. EPIGENETICS MARKET-KEY COMPANY PROFILES 122
16.1 MERCK KGAA 122
16.1.1 Key Facts 122
16.1.2 Business Description 122
16.1.3 Financial Overview 123
16.1.4 Product Portfolio 123
16.1.5 SWOT Analysis 124
16.1.6 Key Developments 125
16.2 THERMO FISHER SCIENTIFIC, INC. 126
16.2.1 Key Facts 126
16.2.2 Business Description 126
16.2.3 Financial Information 127
16.2.4 Product Portfolio 127
16.2.5 SWOT Analysis 128
16.2.6 Key Developments 128
16.3 ABCAM PLC 129
16.3.1 Key Facts 129
16.3.2 Business Description 129
16.3.3 Financial Overview 130
16.3.4 Product Portfolio 130
16.3.5 SWOT Analysis 131
16.3.6 Key Developments 132
16.4 AGILENT TECHNOLOGIES, INC. 133
16.4.1 Key Facts 133
16.4.2 Business Description 133
16.4.3 Financial Overview 134
16.4.4 Product Portfolio 134
16.4.5 SWOT Analysis 135
16.4.6 Key Developments 135
16.5 QIAGEN 136
16.5.1 Key Facts 136
16.5.2 Business Description 136
16.5.3 Financial Overview 137
16.5.4 Product Portfolio 137
16.5.5 SWOT Analysis 138
16.5.6 Key Developments 138
16.6 BIO-RAD LABORATORIES, INC. 139
16.6.1 Key Facts 139
16.6.2 Business Description 139
16.6.3 Financial Information 140
16.6.4 Product Portfolio 140
16.6.5 SWOT Analysis 141
16.6.6 Key Developments 141
16.7 ACTIVE MOTIF 142
16.7.1 Key Facts 142
16.7.2 Business Description 142
16.7.3 Financial Overview 142
16.7.4 Product Portfolio 143
16.7.5 SWOT Analysis 144
16.7.6 Key Developments 144
16.8 PERKIN ELMER, INC. 145
16.8.1 Key Facts 145
16.8.2 Business Description 145
16.8.3 Financial Overview 146
16.8.4 Product Portfolio 146
16.8.5 SWOT Analysis 147
16.8.6 Key Developments 147
16.9 NEW ENGLAND BIOLABS 148
16.9.1 Key Facts 148
16.9.2 Business Description 148
16.9.3 Financial Overview 148
16.9.4 Product Portfolio 148
16.9.5 SWOT Analysis 150
16.9.6 Key Developments 150
16.10 ILLUMINA, INC. 151
16.10.1 Key Facts 151
16.10.2 Business Description 151
16.10.3 Financial Overview 152
16.10.4 Product Portfolio 152
16.10.5 SWOT Analysis 153
16.10.6 Key Developments 153
17. APPENDIX 154
17.1 ABOUT THE INSIGHT PARTNERS 154
17.2 GLOSSARY OF TERMS 155
17.3 METHODOLOGY 157
17.3.1 Coverage 158
17.3.2 Secondary Research 158
17.3.3 Primary Research 159
LIST OF TABLES
TABLE 1. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
TABLE 2. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
TABLE 3. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
TABLE 4. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
TABLE 5. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 65
TABLE 6. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 7. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
TABLE 8. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 66
TABLE 9. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
TABLE 10. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69
TABLE 11. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 12. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
TABLE 13. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 71
TABLE 14. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
TABLE 15. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
TABLE 16. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 17. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 18. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
TABLE 19. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
TABLE 20. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
TABLE 21. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78
TABLE 22. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 79
TABLE 23. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 24. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 79
TABLE 25. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
TABLE 26. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
TABLE 27. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
TABLE 28. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 82
TABLE 29. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84
TABLE 30. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 85
TABLE 31. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85
TABLE 32. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 85
TABLE 33. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 34. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
TABLE 35. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
TABLE 36. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
TABLE 37. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 38. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91
TABLE 39. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 91
TABLE 40. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 91
TABLE 41. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 93
TABLE 42. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
TABLE 43. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
TABLE 44. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
TABLE 45. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 46. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 97
TABLE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 48. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
TABLE 50. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
TABLE 51. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 52. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
TABLE 53. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
TABLE 54. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 103
TABLE 55. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 104
TABLE 56. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 57. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
TABLE 58. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
TABLE 59. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106
TABLE 60. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 106
TABLE 61. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
TABLE 62. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 108
TABLE 63. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109
TABLE 64. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109
TABLE 65. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 109
TABLE 66. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
TABLE 67. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
TABLE 68. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
TABLE 69. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
TABLE 70. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 115
TABLE 71. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 115
TABLE 72. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 115
TABLE 73. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 116
TABLE 74. RECENT PRODUCT LAUNCHES IN THE EPIGENETICS MARKET 118
TABLE 75. RECENT OTHERS IN THE EPIGENETICS MARKET 119
TABLE 76. AGREEMENTS INORGANIC DEVELOPMENTS IN THE EPIGENETICS MARKET 120
TABLE 77. ACQUISITIONS IN THE EPIGENETICS MARKET 121
TABLE 78. GLOSSARY OF TERMS, EPIGENETICS MARKET 155
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC EPIGENETICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 24
FIGURE 2. GLOBAL EPIGENETICS MARKET BY PRODUCT, MARKET SHARE (%), 2017 25
FIGURE 3. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 25
FIGURE 4. GLOBAL EPIGENETICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 26
FIGURE 5. GLOBAL EPIGENETICS MARKET BY END USER, MARKET SHARE (%), 2017 26
FIGURE 6. EPIGENETICS MARKET SEGMENTATION 27
FIGURE 7. EPIGENETICS SEGMENTATION, BY REGION 28
FIGURE 8. EPIGENETICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS 34
FIGURE 9. GLOBAL EPIGENETICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025 35
FIGURE 10. GLOBAL EPIGNETICS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 36
FIGURE 11. GLOBAL EPIGENETICS MARKET BY PRODUCT, 2017 & 2025 (%) 39
FIGURE 12. GLOBAL REAGENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 13. GLOBAL KITS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
FIGURE 14. GLOBAL ENZYMES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
FIGURE 15. GLOBAL INSTRUMENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 16. GLOBAL BIOINFORMATICS TOOLS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 17. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, 2017 & 2025 (%) 46
FIGURE 18. GLOBAL HISTONE MODIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 19. GLOBAL DNA METHYLATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 20. GLOBAL OTHERS TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 21. GLOBAL EPIGENETICS MARKET BY APPLICATION, 2017 & 2025 (%) 50
FIGURE 22. GLOBAL METABOLIC DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 23. GLOBAL ONCOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 24. GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 25. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 26. GLOBAL EPIGENETICS MARKET BY END USER, 2017 & 2025 (%) 56
FIGURE 27. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 28. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 29. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 30. NORTH AMERICA EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 60
FIGURE 31. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 32. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
FIGURE 33. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 34. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 35. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 36. EUROPE EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 73
FIGURE 37. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 38. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
FIGURE 39. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 40. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
FIGURE 41. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
FIGURE 42. ASIA PACIFIC EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86
FIGURE 43. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
FIGURE 44. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
FIGURE 45. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
FIGURE 46. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 48. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 98
FIGURE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 50. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
FIGURE 51. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
FIGURE 52. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
FIGURE 53. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 110
FIGURE 54. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
FIGURE 55. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
FIGURE 56. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
FIGURE 57. GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
FIGURE 58. ORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 118
FIGURE 59. INORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 119
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
